Evidence map›Paper›PMID 34648590›Full record

ArticlePLoS pathogens2021

Genetic targeting of Card19 is linked to disrupted NINJ1 expression, impaired cell lysis, and increased susceptibility to Yersinia infection.

Elisabet Bjanes, Reyna Garcia Sillas, Rina Matsuda, Benjamin Demarco, Timothée Fettrelet, Alexandra A DeLaney, Opher S Kornfeld, Bettina L Lee, Eric M Rodríguez López, Daniel Grubaugh and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. NINJ1: implications for plasma membrane rupture and disease.Biochemical Society transactions · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. The role of NINJ1 in diseases.Cell death discovery · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Inflammasomes primarily restrict cytosolicbioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Elisabet BjanesCell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-2747-7699
Reyna Garcia SillasDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
Rina MatsudaCell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Benjamin DemarcoDepartment of Biochemistry, University of Lausanne, Epalinges, Vaud, Switzerland.ORCID 0000-0002-5537-1381
Timothée FettreletDepartment of Biochemistry, University of Lausanne, Epalinges, Vaud, Switzerland.ORCID 0000-0003-1704-6016
Alexandra A DeLaneyCell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-8903-640X
Opher S KornfeldDepartment of Physiological Chemistry, Genentech Inc., South San Francisco, California, United States of America.
Bettina L LeeDepartment of Physiological Chemistry, Genentech Inc., South San Francisco, California, United States of America.
Eric M Rodríguez LópezDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-3236-9676
Daniel GrubaughDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0003-0497-0138
Meghan A Wynosky-DolfiDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-2985-3918
Naomi H PhilipDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
Elise KrespanDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
Dorothy TovarDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
Leonel JoannasDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0001-6518-4478
Daniel P BeitingDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-2865-4589
Jorge Henao-MejiaInstitute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Brian C SchaeferDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America.ORCID 0000-0001-8877-3507
Kaiwen W ChenDepartment of Biochemistry, University of Lausanne, Epalinges, Vaud, Switzerland.ORCID 0000-0001-5903-3251
Petr BrozDepartment of Biochemistry, University of Lausanne, Epalinges, Vaud, Switzerland.ORCID 0000-0002-2334-7790
Igor E BrodskyCell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0001-7970-872X
University of Pennsylvania · USUniversity of Lausanne · CHChildren's Hospital of Philadelphia · USTarget (United States) · USUniformed Services University of the Health Sciences · US

Funding

T cell receptor-activated autophagy as a regulator of T cell effector responsesR01AI125552 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI CONRADS, THOMAS PATRICK, HE, YOU-WEN · 2017 to 2021
$3.1M
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defenseR01AI139102 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2019 to 2023
$2.8M
Defining the non-apoptotic role of Caspase-8 activity in anti-bacterial immune defenseR01AI128530 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2017 to 2021
$2.0M
Regulation of short-lived myeloid cells by the novel long non-coding RNA MorrbidR01HL136572 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HENAO-MEJIA, JORGE · 2017 to 2021
$2.0M
Dissecting the mechanism of RIPK1 kinase-dependent cell death in control of Yersinia infectionR21AI125924 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2016 to 2017
$459k
Novel role of CARD19 in cell death and anti-bacterial host defenseR21AI135421 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2018 to 2019
$443k
NHLBI NIH HHS R01 HL136572NIAID NIH HHS R01 AI125552NIAID NIH HHS R01 AI128530NIAID NIH HHS R01 AI139102NIAID NIH HHS R21 AI125924NIAID NIH HHS R21 AI135421
6 · The paper itself

Abstract

Cell death plays a critical role in inflammatory responses. During pyroptosis, inflammatory caspases cleave Gasdermin D (GSDMD) to release an N-terminal fragment that generates plasma membrane pores that mediate cell lysis and IL-1 cytokine release. Terminal cell lysis and IL-1β release following caspase activation can be uncoupled in certain cell types or in response to particular stimuli, a state termed hyperactivation. However, the factors and mechanisms that regulate terminal cell lysis downstream of GSDMD cleavage remain poorly understood. In the course of studies to define regulation of pyroptosis during Yersinia infection, we identified a line of Card19-deficient mice (Card19lxcn) whose macrophages were protected from cell lysis and showed reduced apoptosis and pyroptosis, yet had wild-type levels of caspase activation, IL-1 secretion, and GSDMD cleavage. Unexpectedly, CARD19, a mitochondrial CARD-containing protein, was not directly responsible for this, as an independently-generated CRISPR/Cas9 Card19 knockout mouse line (Card19Null) showed no defect in macrophage cell lysis. Notably, Card19 is located on chromosome 13, immediately adjacent to Ninj1, which was recently found to regulate cell lysis downstream of GSDMD activation. RNA-seq and western blotting revealed that Card19lxcn BMDMs have significantly reduced NINJ1 expression, and reconstitution of Ninj1 in Card19lxcn immortalized BMDMs restored their ability to undergo cell lysis in response to caspase-dependent cell death stimuli. Card19lxcn mice exhibited increased susceptibility to Yersinia infection, whereas independently-generated Card19Null mice did not, demonstrating that cell lysis itself plays a key role in protection against bacterial infection, and that the increased infection susceptibility of Card19lxcn mice is attributable to loss of NINJ1. Our findings identify genetic targeting of Card19 being responsible for off-target effects on the adjacent gene Ninj1, disrupting the ability of macrophages to undergo plasma membrane rupture downstream of gasdermin cleavage and impacting host survival and bacterial control during Yersinia infection.

Indexed as

AnimalsCARD Signaling Adaptor ProteinsCell Adhesion Molecules, NeuronalMacrophagesMiceMice, KnockoutNerve Growth FactorsPyroptosisYersinia InfectionsCARD Signaling Adaptor ProteinsCell Adhesion Molecules, NeuronalNerve Growth FactorsNinj1 protein, mouse

Identifiers

PMID34648590
PMCPMC8547626
OpenAlexW3207060296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.